Compare PALT & CARA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Paltalk Inc is a communications software innovator. It operates a network of consumer applications where users can meet, see, chat, broadcast and message in real-time in a secure environment with others in the network. The company's product portfolio includes Paltalk, Camfrog, Tinychat and Vumber. Its consumer applications generate revenue principally from subscription fees and advertising arrangements. The company's majority revenue is generated from live video chat products that are :Paltalk and Camfrog.
Cara Therapeutics Inc is a development-stage biotechnology company involved in the development of novel therapeutics to treat human diseases associated with inflammation, pain, and pruritus. Cara's most advanced compound, CR845, aims to treat acute pain and pruritus. This patented compound has analgesic, anti-inflammatory, and antipruritic properties that can be used for multiple therapeutic applications. Additionally, Cara's objective is to use its proprietary drug-screening technology to develop a future pipeline of first-in-class molecules with analgesic and anti-inflammatory features.